Evaluation of a sustained release form of the oral antidiabetic butylbiguanide (Silubin retard).
D000284:Administration, Oral; D001645:Biguanides / Q000008:administration & dosage* / Q000097:blood / Q000652:urine; D002247:Carbon Isotopes; D003692:Delayed-Action Preparations; D005069:Evaluation Studies as Topic; D006207:Half-Life; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000097:blood / Q000652:urine; D007700:Kinetics; D008297:Male; D008954:Models, Biological; D013607:Tablets; D013997:Time Factors
D001645:Biguanides; D002247:Carbon Isotopes; D003692:Delayed-Action Preparations; D007004:Hypoglycemic Agents; D013607:Tablets